Unesbulin

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameUnesbulin
Drug Alias NameBmi-1PTC-596
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolycomb complex protein BMI-1 inhibitorsTubulin polymerisation inhibitors
TargetsPolycomb complex protein BMI-1Tubulin
Therapy Area/IndicationsOvarian NeoplasmsDiffuse Intrinsic Pontine GliomaGlioma +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPoland +[12] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPtc Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPtc Therapeutics IncThe University Of Oklahoma
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsDiffuse Intrinsic Pontine GliomaGlioma
Inactive IndicationsLeiomyosarcomaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A